0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(2):928–935 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2004-1518 Aurora B Overexpression Associates with the Thyroid Carcinoma Undifferentiated Phe

Alterations in chromosome number (aneuploidy) are common in human neoplasias. Loss of mitotic regulation is believed to induce aneuploidy in cancer cells and act as a driving force during the malignant progression. The serine/theronine protein kinases of aurora family genes play a critical role in the regulation of key cell cycle processes. Aurora B mediates chromosome segregation by ensuring orientation of sister chromatids and overexpression of Aurora B in diploid human cells NHDF (normal human diploid fibroblast) induces multinuclearity. We analyzed Aurora B expression in human thyroid carcinomas. Cell lines originating from different histotypes showed an increase in Aurora B expression. Immunohistochemical analysis of archive samples showed a high expression of Aurora B in anaplastic thyroid carcinomas; conversely, Aurora B expression was not detectable in normal thyroid tissue. Real-time PCR analysis confirmed a strong expression of Aurora B in anaplastic thyroid carcinomas. The block of Aurora B expression induced by RNA interference or by using an inhibitor of Aurora kinase activity significantly reduced the growth of thyroid anaplastic carcinoma cells.

[1]  L. Montagnier,et al.  AGAR SUSPENSION CULTURE FOR THE SELECTIVE ASSAY OF CELLS TRANSFORMED BY POLYOMA VIRUS. , 1964, Virology.

[2]  B. Estour,et al.  Characterization of a human follicular thyroid carcinoma cell line (UCLA RO 82 W-1) , 1989, Virchows Archiv. B, Cell pathology including molecular pathology.

[3]  M. Santoro,et al.  The Kirsten murine sarcoma virus induces rat thyroid carcinomas in vivo. , 1989, Oncogene.

[4]  L. Sobin,et al.  The WHO histological classification of thyroid tumors: A commentary on the second edition , 1989, Cancer.

[5]  M. Santoro,et al.  PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas , 1990, Cell.

[6]  B. Caillou,et al.  Presence of mutations in all three ras genes in human thyroid tumors. , 1990, Oncogene.

[7]  T. Sugimura,et al.  cDNA cloning and characterization of ret activated in a human papillary thyroid carcinoma cell line. , 1990, Biochemical and biophysical research communications.

[8]  M. Parmentier,et al.  Thyroid adenocarcinomas secondary to tissue-specific expression of simian virus-40 large T-antigen in transgenic mice. , 1991, Endocrinology.

[9]  T. Seyama,et al.  Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. , 1992, Cancer research.

[10]  T. Oyama,et al.  Overexpression of p53 as a Possible Prognostic Factor in Human Thyroid Carcinoma , 1993, The American journal of surgical pathology.

[11]  J. Fagin,et al.  High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. , 1993, The Journal of clinical investigation.

[12]  M. Parmentier,et al.  Differentiated carcinomas develop as a consequence of the thyroid specific expression of a thyroglobulin-human papillomavirus type 16 E7 transgene. , 1995, Oncogene.

[13]  G. Fontanini,et al.  Cytokine production by a new undifferentiated human thyroid carcinoma cell line, FB-1. , 1997, The Journal of clinical endocrinology and metabolism.

[14]  D. Wynford‐Thomas,et al.  Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms. , 1997, Hormone research.

[15]  Jian Kuang,et al.  Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation , 1998, Nature Genetics.

[16]  H. Katayama,et al.  Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells. , 1998, Cancer research.

[17]  D. Powell,et al.  The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. , 1998, Cancer research.

[18]  Brian Schryver,et al.  A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers , 1998, The EMBO journal.

[19]  H. Katayama,et al.  Mitotic kinase expression and colorectal cancer progression. , 1999, Journal of the National Cancer Institute.

[20]  B. Spiegelman,et al.  PAX8-PPARγ1 Fusion in Oncogene Human Thyroid Carcinoma , 2000 .

[21]  C. J. Chen,et al.  PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. , 2000, Science.

[22]  B. Bass.  Double-Stranded RNA as a Template for Gene Silencing , 2000, Cell.

[23]  Richard R. Adams,et al.  Essential Roles of Drosophila Inner Centromere Protein (Incenp) and Aurora B in Histone H3 Phosphorylation, Metaphase Chromosome Alignment, Kinetochore Disjunction, and Chromosome Segregation , 2001, The Journal of cell biology.

[24]  Erich A. Nigg,et al.  Cell division: Mitotic kinases as regulators of cell division and its checkpoints , 2001, Nature Reviews Molecular Cell Biology.

[25]  P. Jallepalli,et al.  Chromosome segregation and cancer: cutting through the mystery , 2001, Nature Reviews Cancer.

[26]  A. Fire,et al.  Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. Fuller,et al.  RET Oncogene Activation in Papillary Thyroid Carcinoma , 2001, Advances in anatomic pathology.

[28]  Y. Miyoshi,et al.  Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers , 2001, International journal of cancer.

[29]  W. Earnshaw,et al.  Chromosomal passengers and the (aurora) ABCs of mitosis. , 2001, Trends in cell biology.

[30]  C. Moskaluk,et al.  Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosa. , 2001, Gastroenterology.

[31]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[32]  D. Stoler,et al.  Genomic instability measurement in the diagnosis of thyroid neoplasms , 2002, Head & neck.

[33]  J. Fagin,et al.  Mechanisms of aneuploidy in thyroid cancer cell lines and tissues: evidence for mitotic checkpoint dysfunction without mutations in BUB1 and BUBR1 , 2002, Clinical endocrinology.

[34]  Yu-Li Wang,et al.  The Kinase Activity of Aurora B Is Required for Kinetochore-Microtubule Interactions during Mitosis , 2002, Current Biology.

[35]  Stéphanie Dutertre,et al.  On the role of aurora-A in centrosome function , 2002, Oncogene.

[36]  H. Katayama,et al.  Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability. , 2002, Cancer research.

[37]  M. Jantsch,et al.  The Aurora B Kinase AIR-2 Regulates Kinetochores during Mitosis and Is Required for Separation of Homologous Chromosomes during Meiosis , 2002, Current Biology.

[38]  M. Nikiforova,et al.  BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. , 2003, The Journal of clinical endocrinology and metabolism.

[39]  P. Gattuso,et al.  Genomic DNA Extraction and PCR Amplification of Exon 15 of the BRAF Gene and Exons 1 and 2 of the NRAS Gene , 2003 .

[40]  H. Friess,et al.  Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[41]  J. Swedlow,et al.  Mitotic mechanics: the auroras come into view. , 2003, Current opinion in cell biology.

[42]  Yuri E Nikiforov,et al.  High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. , 2003, Cancer research.

[43]  P. Ladenson,et al.  BRAF mutation in papillary thyroid carcinoma. , 2003, Journal of the National Cancer Institute.

[44]  O. Sieber,et al.  Genomic instability — the engine of tumorigenesis? , 2003, Nature Reviews Cancer.

[45]  Shinichi Suzuki,et al.  BRAF mutations in papillary carcinomas of the thyroid , 2003, Oncogene.

[46]  Hiroki Nagase,et al.  Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human , 2003, Nature Genetics.

[47]  S. Fujita,et al.  Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non‐Hodgkin's lymphoma , 2003, British journal of haematology.

[48]  Stephen S. Taylor,et al.  Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores , 2003, The Journal of cell biology.

[49]  Domenico Coppola,et al.  Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[50]  P. Chieffi,et al.  Aurora B expression in normal testis and seminomas. , 2004, The Journal of endocrinology.